Inclusion Criteria:~* Outpatients~* NINCDS/ADRDA criteria for probable AD~* MMSE at assessment = 10-30~*
Identified informant to accompany patient at all visits~* Stable dose of donepezil, galantamine or rivastigmine
for preceding 12 weeks~
